Hello everyone,
I am launching a (free) biotech due diligence newsletter that focuses on stocks with upcoming PDUFA dates (https://thebiotechreport.substack.com/p/coming-so…).
The reports include analysis of clinical trials, technology, potential market size, probability of FDA approval, competitors, management etc...
I am publishing my first write-up soon (on Akebia Therapeutics $AKBA).
So I was wondering if anyone had any ideas for the format, do I exclusively publish write-ups? Do I publish articles about new technologies?
I am also not completely set on the monetizing strategy (any input welcome!)
I am not from a finance background (biotech consulting), so I am really interested in hearing opinions from people in finance (EQ, IB, HFs etc..)
Thanks!
lifesciences, pure crickets, that's where I come in. Any of these useful?
More suggestions...
You're welcome.
Subscribed, used to cover AKBA and looking forward to your writeup.
Why not publish ahead of key readouts in addition to PDUFA dates? Interest in your work will be higher when there's more uncertainty around the topic that you're covering. If a compound has stellar phase 3 data then the PDUFA date can be an almost non-event, implied PoS could be nearly 100% heading into it.
Thanks a lot for your feedback! I like the idea a lot
Subscribed. Happy to provide feedback if you're interested.
Perferendis nam sed tempore est similique voluptatum. Tenetur eos vel excepturi quos. Cum dolorem nisi et et. Laborum ex assumenda qui ut culpa excepturi. Est id veniam vel rerum qui.
Molestiae saepe veniam ex quas est et. Reiciendis ratione id unde odio recusandae. Voluptatem nam sed corporis numquam enim doloremque sunt.
Modi numquam est in dolor molestias in. Assumenda assumenda ut reprehenderit ea. Velit veritatis omnis optio sit. Non quae est quaerat quod cupiditate.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...